vs

Side-by-side financial comparison of Global Indemnity Group, LLC (GBLI) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $116.7M, roughly 1.7× Global Indemnity Group, LLC). REPLIGEN CORP runs the higher net margin — 6.7% vs 5.5%, a 1.2% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 7.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 2.0%).

Global Indemnity Group LLC is a specialty insurance holding company that provides tailored commercial and personal property and casualty insurance products, as well as surety and reinsurance solutions. It primarily serves small to mid-sized enterprises and niche personal line segments across the United States, focusing on underserved specialty risk categories through its licensed subsidiary insurance carriers.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

GBLI vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.7× larger
RGEN
$197.9M
$116.7M
GBLI
Growing faster (revenue YoY)
RGEN
RGEN
+6.0% gap
RGEN
13.6%
7.6%
GBLI
Higher net margin
RGEN
RGEN
1.2% more per $
RGEN
6.7%
5.5%
GBLI
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
2.0%
GBLI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GBLI
GBLI
RGEN
RGEN
Revenue
$116.7M
$197.9M
Net Profit
$6.5M
$13.3M
Gross Margin
52.5%
Operating Margin
7.9%
9.0%
Net Margin
5.5%
6.7%
Revenue YoY
7.6%
13.6%
Net Profit YoY
-28.5%
143.9%
EPS (diluted)
$0.48
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GBLI
GBLI
RGEN
RGEN
Q4 25
$116.7M
$197.9M
Q3 25
$114.2M
$188.8M
Q2 25
$110.5M
$182.4M
Q1 25
$108.7M
$169.2M
Q4 24
$108.4M
$174.1M
Q3 24
$111.8M
$154.9M
Q2 24
$108.7M
$154.1M
Q1 24
$112.3M
$151.3M
Net Profit
GBLI
GBLI
RGEN
RGEN
Q4 25
$6.5M
$13.3M
Q3 25
$12.5M
$14.9M
Q2 25
$10.3M
$14.9M
Q1 25
$-4.0M
$5.8M
Q4 24
$9.0M
$-30.3M
Q3 24
$12.8M
$-654.0K
Q2 24
$10.1M
$3.3M
Q1 24
$11.4M
$2.1M
Gross Margin
GBLI
GBLI
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
GBLI
GBLI
RGEN
RGEN
Q4 25
7.9%
9.0%
Q3 25
14.1%
8.9%
Q2 25
11.9%
7.6%
Q1 25
-4.7%
3.9%
Q4 24
11.2%
-17.7%
Q3 24
14.2%
-5.1%
Q2 24
11.7%
1.0%
Q1 24
12.7%
1.3%
Net Margin
GBLI
GBLI
RGEN
RGEN
Q4 25
5.5%
6.7%
Q3 25
11.0%
7.9%
Q2 25
9.4%
8.2%
Q1 25
-3.7%
3.4%
Q4 24
8.3%
-17.4%
Q3 24
11.4%
-0.4%
Q2 24
9.3%
2.2%
Q1 24
10.1%
1.4%
EPS (diluted)
GBLI
GBLI
RGEN
RGEN
Q4 25
$0.48
$0.24
Q3 25
$0.86
$0.26
Q2 25
$0.71
$0.26
Q1 25
$-0.30
$0.10
Q4 24
$0.65
$-0.55
Q3 24
$0.92
$-0.01
Q2 24
$0.73
$0.06
Q1 24
$0.82
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GBLI
GBLI
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$65.5M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$706.6M
$2.1B
Total Assets
$1.7B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GBLI
GBLI
RGEN
RGEN
Q4 25
$65.5M
$767.6M
Q3 25
$75.4M
$748.7M
Q2 25
$67.3M
$708.9M
Q1 25
$81.1M
$697.2M
Q4 24
$17.0M
$757.4M
Q3 24
$31.0M
$784.0M
Q2 24
$46.7M
$809.1M
Q1 24
$38.9M
$780.6M
Total Debt
GBLI
GBLI
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GBLI
GBLI
RGEN
RGEN
Q4 25
$706.6M
$2.1B
Q3 25
$704.1M
$2.1B
Q2 25
$695.3M
$2.1B
Q1 25
$687.1M
$2.0B
Q4 24
$689.1M
$2.0B
Q3 24
$686.7M
$2.0B
Q2 24
$667.5M
$2.0B
Q1 24
$659.5M
$2.0B
Total Assets
GBLI
GBLI
RGEN
RGEN
Q4 25
$1.7B
$2.9B
Q3 25
$1.7B
$2.9B
Q2 25
$1.7B
$2.9B
Q1 25
$1.7B
$2.9B
Q4 24
$1.7B
$2.8B
Q3 24
$1.8B
$2.8B
Q2 24
$1.7B
$2.9B
Q1 24
$1.7B
$2.8B
Debt / Equity
GBLI
GBLI
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GBLI
GBLI
RGEN
RGEN
Operating Cash FlowLast quarter
$9.1M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.40×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GBLI
GBLI
RGEN
RGEN
Q4 25
$9.1M
$25.7M
Q3 25
$5.7M
$48.1M
Q2 25
$7.0M
$28.6M
Q1 25
$2.4M
$15.0M
Q4 24
$38.8M
$39.2M
Q3 24
$15.3M
$49.3M
Q2 24
$14.3M
$42.2M
Q1 24
$22.7M
$44.7M
Free Cash Flow
GBLI
GBLI
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
GBLI
GBLI
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
GBLI
GBLI
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
GBLI
GBLI
RGEN
RGEN
Q4 25
1.40×
1.93×
Q3 25
0.45×
3.23×
Q2 25
0.68×
1.92×
Q1 25
2.57×
Q4 24
4.30×
Q3 24
1.20×
Q2 24
1.41×
12.70×
Q1 24
2.00×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GBLI
GBLI

Belmont Core$99.2M85%
Agency And Insurance Services$13.8M12%
Other$3.7M3%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons